Skip to main content
TipRanks
Go Ultimate75% OFF

TenNor Therapeutics Suzhou Ltd. Class H (6872) Income Statement

TenNor Therapeutics Suzhou Ltd. Class H Income Statement

Last quarter (Q4 2025), TenNor Therapeutics Suzhou Ltd. Class H's total revenue was ¥0.00. In Q4, TenNor Therapeutics Suzhou Ltd. Class H's net income was ¥-37.78M. See TenNor Therapeutics Suzhou Ltd. Class H’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23
¥ 0.00¥ 0.00¥ 0.00
¥ 0.00¥ 0.00¥ 0.00
¥ 118.67M¥ 78.00M¥ 122.48M
Depreciation and Amortization¥ 1.58M¥ 2.70M¥ 2.88M
¥ -150.18M¥ -141.35M¥ -186.61M
¥ -118.67M¥ -78.00M¥ -122.48M
¥ -34.57M¥ -67.93M¥ -69.36M
¥ -153.24M¥ -145.93M¥ -191.84M
¥ -153.24M¥ -145.93M¥ -191.84M
Per Share Metrics
Basic EPS¥ -2.96¥ -2.82¥ -3.71
Diluted EPS¥ -2.96¥ -2.82¥ -3.71
Weighted Average Shares Outstanding51.75M51.75M51.75M
Weighted Average Shares Outstanding (Diluted)51.75M51.75M51.75M

Currency in CNY

TenNor Therapeutics Suzhou Ltd. Class H Earnings and Revenue History

-240M-160M-80M00 %0.4 %0.8 %1.2 %EarningsProfit Margin202320242025RevenueEarningsProfit Margin